TEVA UK HOLDCO 2 LIMITED
Get an alert when TEVA UK HOLDCO 2 LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£5.3m
USD 7,111,702
+18.2% vs 2024
Employees
0
Average over period
Profit before tax
-£93k
USD -124,921
-102.9% vs 2024
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | — | — | — | |
| Profit before tax | -£1,569,064,951 | £3,222,290 | -£92,706 | -102.9% | |
| Net profit | -£1,569,064,951 | £3,222,290 | -£92,706 | -102.9% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | £4,463,270 | £5,277,701 | +18.2% | |
| Net assets | — | £4,463,270 | £5,277,701 | +18.2% | |
| Equity | — | £4,463,270 | £5,277,701 | +18.2% | |
| Average employees | — | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Figures converted to GBP from USD at 0.742 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Gearing (liabilities / total assets) | — | 0.0% | 0.0% |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors consider that preparing the financial statements on a going concern basis is appropriate due to the continued financial support of Teva Pharmaceuticals Europe B.V., a fellow group company.”
Significant events
- “During February 2025, under a subscription and settlement agreement, the company allotted to the company's holding company, Teva UK Holdco 1 Limited, 688,906,337 ordinary shares of $1.00 each.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHARLESWORTH, Stephen Michael | Director | 2020-04-29 | Feb 1967 | British |
| COOPER, Dean Michael | Director | 2019-09-17 | Sep 1972 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HERMAN, Doron | Director | 2019-09-17 | 2022-05-07 |
| INNES, Kim | Director | 2019-09-17 | 2020-04-29 |
| KATZ, Yaron Aizik, Mr | Director | 2022-05-07 | 2026-05-29 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Teva Uk Holdco 1 Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-09-17 | Active |
Filing timeline
Last 20 of 37 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-06 | AA | accounts | Accounts with accounts type full | |
| 2026-09-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-09-11 | CH01 | officers | Change person director company with change date | |
| 2026-06-03 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-20 | RP01SH01 | miscellaneous | Legacy | |
| 2025-10-06 | AA | accounts | Accounts with accounts type full | |
| 2025-09-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-14 | SH01 | capital | Capital allotment shares | |
| 2025-02-17 | SH01 | capital | Capital allotment shares | |
| 2025-01-30 | SH01 | capital | Capital allotment shares | |
| 2024-12-12 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-12-10 | SH01 | capital | Capital allotment shares | |
| 2024-10-21 | CS01 | confirmation-statement | Confirmation statement | |
| 2024-10-09 | AA | accounts | Accounts with accounts type full | |
| 2024-06-25 | SH01 | capital | Capital allotment shares | |
| 2023-12-14 | SH01 | capital | Capital allotment shares | |
| 2023-10-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-08-07 | AA | accounts | Accounts with accounts type full | |
| 2023-02-23 | SH01 | capital | Capital allotment shares | |
| 2023-01-03 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 4
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.